This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bardon, S. Articles by Rochefort, H. Search for Related Content PubMed PubMed Citation Articles by Bardon, S. Articles by Rochefort, H.

Steroid Receptor-mediated Cytotoxicity of an Antiestrogen and an Antiprogestin in Breast Cancer Cells¹

Unité d'Endocrinologie Cellulaire et Moléculaire, U 148 INSERM, 60, rue de Navacelles, 34100 Montpellier, France

The antiproliferative and cytotoxic effects of 4-hydroxytamoxifen, an antiestrogen with a high affinity for the estrogen receptor, and of 17ß-hydroxy-11ß-(4-methylaminophenyl)-17-(1-propynyl)estra-4,9-dien-3-one-6-7 (RU486), an antiprogestin with a high affinity for the progestin receptor, have been studied on human breast cancer cell lines in culture. The number of dead cells was evaluated by several techniques (trypan blue stain exclusion, DNA cleavage, lactic dehydrogenase activity, morphological changes, and cloning efficiency in soft agar) and found to be increased both by the antiestrogen and the antiprogestin at concentrations correlating with the affinities for their respective receptors. This cytotoxic effect was prevented by the occupation of the respective receptors with estrogen and progestin and was not found in the estrogen receptor- and progestin receptor-negative MDA MB 231 and BT20 cell lines. The contrast between the ultrastructural modifications of chromatin and the integrity of mitochondria suggested that the antihormone-induced cell death was by apoptosis. We conclude that in addition to the receptor-mediated cytostatic activity and the nonspecific cytotoxic activity, antiestrogens trigger a third type of effect that we designate as "receptor-mediated cytotoxic." Similar conclusions can be drawn for the antiprogestin RU486, indicating moreover that the antihormone and antiproliferative activities of this drug are clearly dissociated. The mechanism of these receptor-mediated cytotoxic activities of antiestrogen and antiprogesterone is not known but does not seem to be explained entirely by the antihormone activity of these drugs.

¹ Supported by the Institut National de la Santé et de la Recherche Médicale and the Ligue Nationale Contre le Cancer.

² To whom requests for reprints should be addressed.

Received 11/13/85. Revised 5/12/86. Revised 8/26/86. Revised 11/ 3/86. Accepted 12/ 2/86.

This article has been cited by other articles:

				D Montanaro, M Maggiolini, A G Recchia, R Sirianni, S Aquila, L Barzon, F Fallo, S Ando, and V Pezzi Antiestrogens upregulate estrogen receptor {beta} expression and inhibit adrenocortical H295R cell proliferation J. Mol. Endocrinol., October 1, 2005; 35(2): 245 - 256. [Abstract] [Full Text] [PDF]

				M. A. Awal, M. Kurohmaru, M. Ishii, B. B. Andriana, Y. Kanai, and Y. Hayashi Mono-(2-ethylhexyl) Phthalate (MEHP) Induces Spermatogenic Cell Apoptosis in Guinea Pig Testes at Prepubertal Stage In Vitro International Journal of Toxicology, November 1, 2004; 23(6): 349 - 355. [Abstract] [Full Text] [PDF]

				V. T. Gaddy, J. T. Barrett, J. N. Delk, A. M. Kallab, A. G. Porter, and P. V. Schoenlein Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells Clin. Cancer Res., August 1, 2004; 10(15): 5215 - 5225. [Abstract] [Full Text] [PDF]

				G. Bompard, C. Puech, C. Prebois, F. Vignon, and G. Freiss Protein-tyrosine Phosphatase PTPL1/FAP-1 Triggers Apoptosis in Human Breast Cancer Cells J. Biol. Chem., November 27, 2002; 277(49): 47861 - 47869. [Abstract] [Full Text] [PDF]

				T. M. GOEPFERT, M. MCCARTHY, F. S. KITTRELL, C. STEPHENS, R. L. ULLRICH, B. R. BRINKLEY, and D. MEDINA Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells FASEB J, November 1, 2000; 14(14): 2221 - 2229. [Abstract] [Full Text]

				M. Dowsett, J. M. Dixon, K. Horgan, J. Salter, M. Hills, and E. Harvey Antiproliferative Effects of Idoxifene in a Placebo-controlled Trial in Primary Human Breast Cancer Clin. Cancer Res., June 1, 2000; 6(6): 2260 - 2267. [Abstract] [Full Text]

				B. Perillo, A. Sasso, C. Abbondanza, and G. Palumbo 17beta -Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence Mol. Cell. Biol., April 15, 2000; 20(8): 2890 - 2901. [Abstract] [Full Text]

				G. Liu, J. A. Schwartz, and S. C. Brooks Estrogen Receptor Protects p53 from Deactivation by Human Double Minute-2 Cancer Res., April 1, 2000; 60(7): 1810 - 1814. [Abstract] [Full Text]

				W Bursch, K Hochegger, L Torok, B Marian, A Ellinger, and R. Hermann Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments J. Cell Sci., January 4, 2000; 113(7): 1189 - 1198. [Abstract] [PDF]

				E. A. Musgrove, C. S. L. Lee, A. L. Cornish, A. Swarbrick, and R. L. Sutherland Antiprogestin Inhibition of Cell Cycle Progression in T-47D Breast Cancer Cells Is Accompanied by Induction of the Cyclin-Dependent Kinase Inhibitor p21 Mol. Endocrinol., January 1, 1997; 11(1): 54 - 66. [Abstract] [Full Text]

				P. T. Jain, M. J. Fitzpatrick, P. C. Phelps, I. K. Berezesky, and B. F. Trump Studies of Skin Toxicity In Vitro: Dose-Response Studies on JB6 Cells Toxicol Pathol, January 1, 1992; 20(3-1): 394 - 404. [Abstract] [PDF]

				S. S. Legha Tamoxifen in the Treatment of Breast Cancer Ann Intern Med, August 1, 1988; 109(3): 219 - 228. [Abstract] [PDF]